Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Interim-report January – September 2018

Continued strong demand new city district development project has been initiated· Rental income increased to SEK 1,864m (1,688). In an identical portfolio, income rose by approximately 10 per cent. · Net operating income increased to SEK 1,389m (1 230). In an identical portfolio, net operating income rose by approximately 12 per cent. · The surplus ratio was 75 per cent (73). · Profit from property management increased with 25 per cent to SEK 895m (713). · Realised and unrealised changes in value amounted to SEK 6,213m (4,452). · Net lettings during the period totalled SEK

Ahlsell awarded work-site logistics contract for the construction of Karlatornet in Gothenburg

Ahlsell has been awarded the work-site logistics contract for the construction of Karlatornet, the tallest building ever built in the Nordic region. Karlatornet, which is to be built in the new Karlastaden district in Gothenburg, will have 73 floors and be 245 meters high. The tower is expected to be ready for its first residents in 2021 and the new district is planned to be completed a few years later. The contract covers the full logistic solution for the project, and Ahlsell will have some 40 employees involved in the logistics throughout the project time. For Ahlsell, the project

Nomination Committee for ÅF AB (publ) appointed

The following members have, in accordance with the procedure adopted by the Annual General Shareholders Meeting, been appointed to the ÅF Nomination Committee. -              Anders Narvinger, Chairman of the Board              -              Magnus Olofsson, (Chairman of the Nomination Committee) appointed by Stiftelsen ÅForsk -              Johan Strandberg, appointed by SEB Investment Management -              Lilian Fossum Biner, appointed by Handelsbanken Asset Management -              Monica Åsmyr, appointed by Swedbank Robur Fonder -              Niklas Ringby,

Bactiguard receives product approval in Egypt

The product approval for Bactiguard’s urinary (Foley) catheters has been announced by the Egyptian Ministry of Health. This opens new opportunities for Bactiguard in providing effective infection prevention in the most populous country in North Africa and the Middle East.“We are finally through the registration process in Egypt, which started more than an year ago and was longer than expected. This is a breakthrough and together with our distributor Heal Pharma, we can now start the launch activities in the most populous country in the region”, says Jonas Östregård, SVP Sales and continues:

Cxense ASA: Adjustment of purchase price re acquisition of Enreach Solutions Oy by issue of shares

Reference is made to the stock exchange announcement from Cxense ("Cxense" or the "Company") on 30 April 2018 regarding the acquisition of Enreach Solutions Oy.    In connection with the final purchase price adjustment in the transaction agreement, the board of Cxense has today issued 7,576 new shares to Enreach Solutions AB, the seller of Enreach Solutions Oy, in addition to the 123,789 shares issued on 30 April 2018. The new shares were issued at a subscription price of NOK 55.    The share capital increase is expected to be registered with the Norwegian Register of Business

Citycon Oyj’s Interim Report for 1 January – 30 September 2018: Solid operating performance continued and administrative expenses declined significantly.

Citycon Oyj   Interim Report   18 October 2018 at 09:00 hrs- Occupancy remained at a high level of 96.1%.- Successful opening of newest asset Mölndal Galleria in Gothenburg Sweden.- Divestments conducted in 2017 and in 2018 as well as weaker currencies impacted net rental income and EPRA Earnings as expected.- Cost savings initiatives progressed well and administrative expenses decreased significantly by 14% year-on-year.- Fair value change of investment properties was EUR -54.2 million mainly driven by secondary assets in Finland and Norway.- Loan-to-value (LTV) increased to 48.2%

Invitation to presentation of ICA Gruppen’s Q3 report

ICA Gruppen will publish its Q3 report 2018 on Thursday 25 October. In conjunction to this, we are pleased to issue this invitation to a press and analyst telephone conference. ICA Gruppen’s CEO Per Strömberg and CFO Sven Lindskog will present the interim report with the possibility to ask questions afterwards. The presentation can be followed at http://www.icagruppen.se/en/investors Time: Thursday 25 October 2018 at 10.00 CET If you would like to ask questions, please dial in: SE: +46850639549 UK: +442030089816 A recorded version of the audio cast will be available on the

3 new patents granted to Svenska Aerogel

Nasdaq First North-listed Svenska Aerogel is strengthening the patent portfolio with an additional 3 patents for the use of Quartzene®. These patents initially concern Sweden and will be expanded to Europe / globally, which strengthens Svenska Aerogel's commercial product development.The three patents relate briefly: • Filtration - absorption of formaldehyde • Filtration - absorption of ethylene • Improved printability "Working actively with our intellectual property is an important part of developing commercially strong products that are protected. These 3 new patents

INTERIM REPORT JANUARY - SEPTEMBER 2018

Positive effects of strategic efforts, challenging external factors During the third quarter, implementation of the strategic plan continued at a high pace. The quarter was also affected by challenging external factors. The sales trend was negatively affected by the hot summer, and increased raw material prices for timber continued to negatively impact the gross margin. The sales trend was also negatively impacted by the choice to decrease unprofitable sales in Skånska Byggvaror. Year-on-year Byggmax Group’s sales decreased 5.5 percent in the quarter, and profitability measured as EBITDA

Interim report, January – September 2018

Continued positive development of revenues and profitsThe third quarter in brief · Revenues increased by 11% to SEK 725 (653) million. Growth in local currencies was 4%. Change in accounting principles has affected revenues for the quarter negatively by SEK 32 million. · EBITDA increased by 10% and amounted to SEK 52.9 (48.0) million. · Profit before tax increased by 18% to SEK 37.4 (31.7) million. · Profit after tax increased by 14% to SEK 27.8 (24.3) million. · Profit per share amounted to 3.02 (2.60) SEK. The first nine months in brief · Revenues were unchanged

Interim report January-September 2018

Quarter 3, 2018 · Incoming orders amounted to SEK 817.9m (761.0), which currency adjusted is an increase of 1.2 percent compared with the same period last year. · Net sales amounted to SEK 835.2m (768.7), which currency adjusted is an increase of 2.5 percent compared with the same period last year. · Operating profit was SEK 50.6m (69.3), giving an operating margin of 6.1 percent (9.0). · Net profit was SEK 32.9m (42.9). · Earnings per share were SEK 0.94 (1.22).* January – September, 2018 · Incoming orders amounted to SEK 2,511.7m (2,341.5), which currency adjusted

Enzymatica AB: The Board of Directors of Enzymatica AB decides on rights issue of SEK 98.7 million

Press release October 18, 2018 The Board of Directors of Enzymatica AB decides on rights issue of SEK 98.7 million The Board of Directors of Enzymatica AB (publ) has decided to carry out a rights issue of a maximum of SEK 98,678,187.20 with preferential rights for existing shareholders. The purpose of the rights issue is to finance continued marketing campaigns and clinical studies on the efficacy of ColdZyme besides repaying a bridge loan. The rights issue is subject to approval by an Extraordinary General Meeting to be held on November 5, 2018. Under the terms of the rights issue,

Polygiene Strengthens Marketing Department with New Hire

The appointment of Rebecka Harvyl as marketing manager will strengthen the marketing team with her additional skill set and professional background. Harvyl will be situated at the Polygiene headquarters in Malmö, Sweden.Harvyl comes with a strong background in project management within marketing where her latest employment was at Sweden’s most well-known candy store chain, Hemmakväll. She will now work with marketing responsibilities for the EMEA region, as well as oversee projects ranging from graphic production, printed materials, to social media management. ”I am looking forward to

Interim Report for Duni AB (publ) 1 January – 30 September 2018

Margins under pressure from higher pulp prices – efficiency program initiated1 july – 30 september · Net sales amounted to SEK 1,190 m (1,082). Adjusted for exchange rate movements, net sales increased by 2.7%. Organic growth for the quarter was 0.8%. · Earnings per share after dilution amounted to SEK 1.39 (1.68). · Price increases to compensate for rising raw materials prices have been implemented and further price increases have been initiated. 1 january – 30 september · Net sales amounted to SEK 3,467 m (3,188). Adjusted for exchange rate movements, net sales

Interim report January-September 2018 Nordax Bank AB

Business development private loans New lending continued to have a strong development and amounted to 4.3 bn SEK for the nine-month period, an increase with 20 per cent compared to the corresponding period in 2017. The two most important factors behind the positive development has been a strong development in Finland and a improved customer offering in the broker channel. Business development mortgages The interest in Nordax mortgage product, which was launched during the 2nd quarter 2018, has been very high. Since mid september the marketing for the product has increased through

Enzymatica AB: Enzymatica signs agreement for the Japanese market

Press release October 18, 2018 Enzymatica signs agreement for the Japanese market Enzymatica has entered into an agreement with a large Japanese pharmaceutical company regarding registration, marketing, distribution and sales of ColdZyme® Mouth Spray for common cold. The agreement provides Enzymatica with access to one of the world's largest health care markets, with a population of about 127 million and a cough and cold market with annual sales of almost SEK 10 billion. The agreement is an important component in Enzymatica's growth strategy for international expansion. The

Elisa’s Interim Report Q3 2018

ELISA CORPORATION INTERIM REPORT RELEASE 18 OCTOBER 2018 AT 8:30 AM Elisa’s Interim Report January–September 2018 Third quarter 2018 · Revenue amounted to EUR 454 million (454) · EBITDA was EUR 169 million (165) and EBIT was EUR 110 million (109) · Profit before tax was EUR 104 million (104) · Earnings per share were EUR 0.53 (0.53) · Comparable cash flow after investments was EUR 85 million (71) · Mobile post-paid voice ARPU was EUR 20.4 (20.4 in previous quarter) · Mobile post-paid voice churn was 17.2 per cent (17.4 in previous quarter) · Mobile service

Ericsson reports third quarter results 2018

Third quarter highlights   · Sales as reported increased YoY by 9% and sales adjusted for comparable units and currency increased by 1%. · Segment Networks showed a sales growth adjusted for comparable units and currency of 5% YoY with strong sales growth in North America as well as in Europe and Latin America. · Gross margin was 36.5% (26.9%). Gross margin excluding restructuring charges improved to 36.9% (28.5%), driven mainly by cost reductions, the continued ramp-up of Ericsson Radio System (ERS) and good progress in reviewing Managed Services contracts. · Operating margin

Powerbox’s S-CAP BOOST power solution named as finalist in prestigious Elektra Awards

Powerbox , one of Europe’s largest power supply companies and a leading force for four decades in optimizing power solutions for demanding applications, has announced that its new S-CAP BOOST  platform has been selected by the Elektra Awards committee as a finalist in the highly contested Power System Product of the Year category. Powerbox’s S-CAP BOOST is a supercapacitor boost technology that offers backup and peak power solutions for industrial and medical applications. Based on the latest supercapacitor technology

Atea reports financial results for Q3 2018

Atea reported very strong growth in revenue and operating profit outside of its Danish business in Q3 2018.  In Denmark, the public contracting authorities accepted Atea’s self-cleaning program in September, allowing the company to return to business on normal terms.Financial highlights are as follows: ·  Revenue: NOK 7.1 billion (NOK 6.7 billion) ·  Gross profit: NOK 1.7 billion (NOK 1.6 billion) ·  EBITDA before share based compensation: NOK 249 million (NOK 272 million) ·  EBIT: NOK 132 million (NOK 176 million) Outside of Denmark, Atea reported revenue growth of 15.7%

Tele2 AB: Interim Report Third Quarter 2018

Stockholm –  Tele2 AB (“Tele2”) (Nasdaq Stockholm: TEL2 A and TEL2 B) today announces its consolidated results for the third quarter 2018.CEO comment by Allison Kirkby“The final quarter before the closing of the merger with Com Hem was once again a quarter of solid business trends, allowing us to make another upgrade of our full-year guidance. Mobile end-user service revenue growth was 5 percent and adjusted EBITDA growth was 9 percent, like-for-like. Our investment markets continue to outperform while Sweden remained resilient, returning to mid-single digit EBITDA growth as the drag from

Carbon fibre can store energy in the body of a vehicle

A study led by Chalmers University of Technology, Sweden, has shown that carbon fibres can work as battery electrodes, storing energy directly. This opens up new opportunities for structural batteries, where the carbon fibre becomes part of the energy system. The use of this type of multifunctional material can contribute to a significant weight-reduction in the aircraft and vehicles of the future – a key challenge for electrification. Passenger aircraft need to be much lighter than they are today in order to be powered by electricity. A reduction in weight is also very important for

BioArctic: Eisai to present additional data from BAN2401 Phase 2b study in early Alzheimer’s disease and the presentation will be webcast live from CTAD

Stockholm, Sweden, October 18, 2018 – BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) announced today that Eisai will present additional data on the anti-amyloid (Aβ) protofibril antibody BAN2401 clinical Phase 2b study at the 11th Clinical Trials on Alzheimer’s Disease (CTAD) conference, October 24-27, 2018 in Barcelona, Spain. The presentation will be given during the symposium “Clinical and Biomarker Updates from BAN2401 Study 201 in Early AD” where additional data will be highlighted from the BAN2401 Phase 2b study (ClinicalTrials.gov identifier: NCT01767311). Presentation of

Rättelse av pressmeddelande den 17 oktober 2018: ”Kommuniké från årsstämman i Zutec Holding AB (publ)”

Rättelsen avser antalet styrelseledamöter samt utsedda styrelseledamöter. Stämman beslutade att antalet styrelseledamöter i Bolaget ska uppgå till sex. Vidare omvaldes även styrelseledamoten Gerard Jones för tiden intill slutet av nästa årsstämma. Det felaktiga pressmeddelandet distribuerades den 17 oktober 2018, kl. 16.10. En uppdaterad version av pressmeddelandet följer nedan. Årsstämma har idag hållits i Zutec Holding AB (publ) (”Bolaget”) i MAQS Advokatbyrås lokaler på Mäster Samuelsgatan 20. Efter att det konstaterats att den av styrelsen föreslagna ordföranden för stämman, Brian

There are no items matching the current filter
There are no more items matching the current filter
Back to top